Embecta (Nasdaq:EMBC) today posted fourth-quarter financial results that proved mixed compared to the consensus forecast on ...
Ripple Therapeutics announced today that it entered into a deal with a Bausch + Lomb affiliate related to drug delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback